Simon Hayward to Kallikreins
This is a "connection" page, showing publications Simon Hayward has written about Kallikreins.
Connection Strength
0.632
-
Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients. Prostate. 2019 02; 79(3):259-264.
Score: 0.606
-
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells. Eur Urol. 2013 Nov; 64(5):753-61.
Score: 0.026